Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS launches journal on name change
2008-11-14

 

At the launch of the journal on name change were, from the left: Prof. Johan Lubbe, research associate of the Unit for Language Management at the UFS and guest editor of the magazine, Dr Lucie Möller, expert on geographical names and place name expert - and also an occasional member of the United Nations' committee of experts, Dr Peter Raper, research associate of the Unit for Language Management at the UFS, and Prof. Theo du Plessis, Director of the Unit for Language Management at the UFS. The magazine is dedicated to Dr Möller.
Photo: Lacea Loader

UFS launches journal on name change

From all the language issues coved in the English and Afrikaans printed media, the name change of place names is receiving the most attention. This is according to Prof. Johan Lubbe, research associate from the University of the Free State’s (UFS) Unit for Language Management, during the recent launch of a journal on name change on the Main Campus in Bloemfontein.

In the journal it is found, among other, that, as a result of the nature of the new democratic foundation of the ANC controlled government which puts the interests of the majority first, there is a move in the thinking and execution of name change. In this way not only names change but art, culture and heritage matters are democratically thought through and planned.

“As a directive from the South African Language Board (Pansalb), the Unit for Language Management at the UFS annually compiles the SA Language Monitor which reports on the language rights situation in South Africa as mainly reported by the print media. Issues about name change appeared throughout and this is why the unit decided to publish a journal with various perspectives on this,” said Prof. Lubbe, who is also the guest editor of the journal.

Other topics discussed in the journal include, among others, language visibility, a historical overview of the change in place names, the Khoisan influence on naming and naming amongst Xhosa speakers.

In a contribution on language visibility it is found that geographical naming policy and the national language policy does not correlate and language visibility as language mechanism is not considered. In a historical overview on the change of place names it is found that name change was never a calculated, political process and only after 2000 mention was made of a conscious, orchestrated process of name change.

In a further contribution on the name change of Johannesburg International airport, it was found that the government, by ignoring the sentiments of the minority, made itself guilty of splitting the nation in spite of pronunciations that nation building is a priority. Where African languages are concerned, it was found that the English name is increasingly being discarded in favour of the Xhosa name. This is apparently connected to the language debate in South Africa.

The journal, “Kritiese perspektiewe op naamsverandering” (“Critical perspectives on name change”) is a supplement to the “Acta Academica”, an accredited national journal that is independently publishing selected research articles in the human sciences and interdissiplinary fields. Nine cooperators from across the country made contributions to the journal.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
14 November 2008
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept